Navigation Links
First Annual Autism Conference at Packard Children's and Stanford Brings Parents and Researchers Together
Date:5/20/2008

PALO ALTO, Calif., May 20 /PRNewswire/ -- Parents of children with autism often grapple with a bewildering array of questions and choices: "Did I do something to cause the disorder? Could it be genetic? What is it like to be a child with autism? Are there new medications or therapies that might alleviate some of my child's symptoms?"

On May 31, family members, caregivers and teachers of children with autism will have a unique opportunity to hear from researchers on the front line of the difficult disorder. 'Recent Advances in Autism Treatment and Research' is the first in what organizers from Lucile Packard Children's Hospital and Stanford University hope will be an annual event aimed at sharing the latest in autism research with the families of affected children.

"We're engaging family members and caregivers of children with autism," said Carl Feinstein, MD, the Endowed Director of Psychiatry at Packard Children's. "We want to share with the parents what we have learned and learn from the parents what they know."

Feinstein, a professor of psychiatry and behavioral sciences at Stanford's medical school, co-directs the Stanford Autism Working Group -- a collaboration of physicians, geneticists, neuroscientists, cell biologists, and bioengineers dedicated to discovering the neurological and biological basis of the complex disorder. The conference is meant to be the first in a series of productive exchanges between parents and members of the group.

"Parents are powerful advocates for their kids," said child psychiatrist Antonio Hardan, MD, who directs the autism and developmental disabilities clinic at Packard Children's. "But it is very important for them to be informed about the risks and benefits of intervention. We want to empower them by giving them a balanced view of the latest research and medical treatments."

At the all-day conference on the Stanford campus, Hardan, an assistant professor of psychiatry and behavioral sc
'/>"/>

SOURCE Lucile Packard Children's Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... for advanced fluid applications and designed for continuous operation up to 1500 bar. ... sterilization-in-place, ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer ...
(Date:7/29/2015)... -- Sanofi, un leader mondial et ... le premier semestre 2015. Le Directeur Général ... Visionner l,interview vidéo et lire la transcription :  ... sommaire de l,interview :  - Résultats ... - Diabète - Praluent ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... May 11 /PRNewswire-Asia-FirstCall/ -- China,Baicaotang Medicine Ltd. (OTC Bulletin Board: ... in the, Guangxi Province of China announced today that ... the,Company. , , , ... Mr. Tang Hui Tian , Chairman and CEO of CBT, ...
... China , May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ... on researching, developing, manufacturing and marketing,biopharmaceutical products, today announced that it will ... on May 16, 2010 ,at 8:00pm (Eastern). , ... Following ...
... GARDENA, Calif. , May 11 Trans World Alloys ... proudly announces the grand opening of their state-of-the-art, 40,000 square foot service center ... , , ... , , ...
Cached Biology Technology:Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd. 2Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd. 33SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010 2Titanium and Aluminum Distributor, Trans World Alloys Relocates to Its Newly Built, State-of-the-Art Headquarters in Gardena, California 2
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... The presence of drug-resistant, pathogenic bacteria on uncooked poultry ... to antibiotic use in production, according to researchers at ... study is the first to directly compare bacterial contamination ... producers who use antibiotics and from those who claim ...
... first comprehensive survey of gene activity in the X ... variation among individuals, according to new work by researchers ... Policy (IGSP) and Pennsylvania State University. , The results ... traits among women and between males and females, in ...
... the University of Maryland have identified a cricket living ... Finicky mating behavior appears to be the driving force ... scientists wrote in the Jan. 27 issue of Nature ... differences in the pulse rates of male courtship songs, ...
Cached Biology News:Drug-resistant bacteria on poultry products differ by brand 2Drug-resistant bacteria on poultry products differ by brand 3Variation in women's X chromosomes may explain differences among individuals, between sexes 2Variation in women's X chromosomes may explain differences among individuals, between sexes 3Cricket's finicky mating behavior boosts biodiversity 2Cricket's finicky mating behavior boosts biodiversity 3
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
... is designed to allow neomycin/kanamycin selection ... The loxP-PGK-gb2-neo-loxP template encodes the neomycin/kanamycin ... promoter (gb2) for expression of kanamycin ... promoter (PGK) for expression of neomycin ...
... These precision 5mm diameter, 7 inch long PYREX ... for compatibility with ground joints, valves, and vacuum ... spectrometers running from 300 to 500MHz. They have ... I.D. of 4.20 + 0.013-0.000mm. These NMR tubes ...
Biology Products: